We first attempted to assay histone H4-Ac as a surrogate marker for KAT5 activity along with endogenous p27 and Ki67 levels by IHC in FFPE tumor samples and, also, by FACS analysis of freshly fixed and permeabilized samples (e.g., Fig. 1h). The gene discussed is KAT5; the disease is neoplasm.